Mathioudakis, A. G., Abroug, F., Agusti, A., Ananth, S., Bakke, P., Bartziokas, K., Beghe, B., Bikov, A., Bradbury, T., Brusselle, G., Cadus, C., Coleman, C., Contoli, M., Corlateanu, A., Corlateanu, O., Criner, G. J., Csoma, B., Emelyanov, A., Faner, R., Fernandez Romero, G., Hammouda, Z., Horváth, P., Huerta Garcia, A., Jacobs, M., Jenkins, C., Joos, G., Kharevich, O., Kostikas, K., Lapteva, E., Lazar, Z., Leuppi, J. D., Liddle, C., Linnell, J., López-Giraldo, A., McDonald, V. M., Nielsen, R., Papi, A., Saraiva, I., Sergeeva, G., Sioutkou, A., Sivapalan, P., Stovold, E., Wang, H., Wen, F., Yorke, J., Williamson, P. R., Vestbo, J., & Jensen, J. (2022). eRS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. European respiratory journal, 59(5), . http://access.bl.uk/ark:/81055/vdc_100172060710.0x00004d